PMV Pharmaceuticals, Inc. [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • September 21st, 2020 • PMV Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2020 Company Industry JurisdictionPMV Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [●] shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company (the “Firm Shares”) and, at the election of the Underwriters, up to [●] additional shares (the “Optional Shares”) of Common Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).